Market Research Reports, Inc. has announced the addition of Interventional Cardiology Global Market - Forecast to 2023” research report to their website www.MarketResearchReports.com
Lewes, DE -- (SBWIRE) -- 03/10/2017 -- Interventional cardiology specifically deals with the catheter based treatment of cardiovascular and structural heart diseases. Products of interventional cardiology market are Catheters, Interventional Diagnostic Catheters, stents, valves, transcatheter heart pump and others. Catheters are segmented into Guide Catheter, Balloon Catheter, Atherectomy Catheters, Thrombectomy Catheters, and Ablation Catheters.
Interventional Diagnostic Catheters are segmented into Intravascular ultrasound (IVUS), Fractional flow reserve (FFR), Optical coherence tomography (OCT), Angiograph, Pulmonary artery catheter, Electrophysiology catheter. Stents are further categorised into bare metal stents, drug eluting stents, Bioresorbable stents and Stent grafts. Valves are further divided into Transcatheter Aortic Valve, Annuloplasty Ring, Mitral Clip, and Valvuloplasty. Others are segmented into closure devices (Occluders), Inferior vena cava filters, Guide wires, Transcatheter pacemaker, and accessories.
Applications of Interventional cardiology market are segmented into Diagnostic catheterization, Coronary Interventions, Peripheral interventions and Structural Heart. Coronary intervention application is sub-segmented into Aortic aneurysm (EAVR, TEVAR), Coronary Thrombectomy, PCTA, Coronary Cardiac Ablation and others. Peripheral interventions are sub-segmented into Peripheral Aneurysm, Peripheral Thrombectomy, Peripheral Angioplasty, Peripheral Ablation, Pulmonary embolism, and others. Structural heart is further sub-segmented into Valve replacement, Valve repair, Heart Assist Device, Congenital heart defect and others.
The interventional cardiology global market is expected to grow at a CAGR of high single digit CAGR to reach $46,124.1 million by 2023. Among the Interventional cardiology products, the stents market dominated the products market by occupying a largest share. At the same time, Transcatheter heart pump market is the fastest growing segment projected to grow at a high double digit CAGR. In applications, Coronary Interventions is the largest segment and Structural Heart is the fastest growing segment with the strong CAGR.
Geographical wise, North America is the largest market followed by Europe and Asia-Pacific. The APAC region is projected to be the fastest growing region suggesting an opportunities for growth and likely to get attention of new investors in the interventional cardiology market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases, ageing population and government initiatives in establishing innovative technologies.
Increasing incidences of cardiovascular diseases due to change in lifestyle, Demand for minimally invasive treatment due to less complication, Rise in the number of Cardiovascular disorders and ageing population, awareness of minimally invasive procedures and newly invented devices, raise in number of clinical studies performed are some of the drivers in the Interventional cardiology global market. Many entry level barriers, stringent regulation and lack of skilled and trained professionals are some of the factors hampering the growth of Interventional cardiology market.
The interventional cardiology global market is a consolidated, highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the interventional cardiology market are Abbott Laboratories (U.S.), Boston Scientific (U.S.), B. Braun Melsungen AG (Germany), C.R. Bard, Inc. (U.S.), Edwards Lifesciences (U.S.), Medtronic PLC (Ireland), Terumo Corporation (Japan), Johnson & Johnson (U.S.).
Spanning over 511 pages "Interventional Cardiology Global Market - Forecast to 2023" report covers Executive Summary, Introduction, Market Analysis, Interventional Cardiology Global Market, By Product, Interventional Cardiology Global Market, By Application, Regional Analysis, Company Developments, Major Companies. This Report Covered 146 Companies Few Are - Abbott Laboratories, Abiomed, B.Braun Melsungen, Ag, Boston Scientific Corporation, C.R.Bard, Inc., Cook Medical, Inc., Edwards Lifesciences, Johnson & Johnson, Medtronic, Terumo Corporation, W.L. Gore & Associates, Inc., Abbott Laboratories, Abiomed, Inc., Acandis, Accellent Inc., Acist Medical Systems, Admedes Schuessler Gmbh, Alpha Medical, Amg International Gmbh.
For more information Visit at: http://www.marketresearchreports.com/iq4i/interventional-cardiology-global-market-forecast-2023
Find all Medical Devices Reports at: http://www.marketresearchreports.com/medical-devices
About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.
Yearly/Quarterly Report Subscription: http://www.marketresearchreports.com/subscriptions